Vincerx Pharma (VINC) SEC Filings & 10K Form → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free VINC Stock Alerts $0.85 +0.02 (+2.41%) (As of 05/9/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Recent Vincerx Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/03/20248:00 AMProsight Management, LP (Filed by)Vincerx Pharma (Subject)Form SC 13G04/29/20244:14 PMVincerx Pharma (Filer)Form 424B504/10/20243:03 PMVincerx Pharma (Filer)Form DEFA14A04/10/20243:09 PMVincerx Pharma (Filer)Form ARS04/09/20244:09 PMGOLDMAN SACHS GROUP INC (Filed by)GOLDMAN SACHS GROUP INC (Filed by)Vincerx Pharma (Subject)Form SC 13G/A04/08/20243:35 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/29/20243:12 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/29/20242:14 PMVincerx Pharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/29/20242:26 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/08/20246:58 PMTHOMAS TOM C (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/08/20247:00 PMHamdy Ahmed MD (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/08/20247:04 PMSeelenberger Alexander A. (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 03/08/20247:08 PMIzumi Raquel E. (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/13/20246:05 PMBANK OF AMERICA CORP /DE/ (Filed by)Vincerx Pharma (Subject)Form SC 13G02/05/20244:35 PMGOLDMAN SACHS GROUP INC (Filed by)GOLDMAN SACHS GROUP INC (Filed by)Vincerx Pharma (Subject)Form SC 13G/A01/16/20245:05 AMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/15/20233:05 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/10/20235:27 PMIzumi Raquel E. (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/10/20235:28 PMTHOMAS TOM C (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/10/20235:28 PMHamdy Ahmed MD (Reporting)Vincerx Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/07/20236:01 AMVincerx Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/07/20236:02 AMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/20/20233:05 PMVincerx Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: Avalo Therapeutics SEC Filings Talphera SEC Filings Orgenesis SEC Filings NeuroSense Therapeutics SEC Filings Indaptus Therapeutics SEC Filings Galecto SEC Filings Aptorum Group SEC Filings Minerva Neurosciences SEC Filings VBI Vaccines SEC Filings NeuroBo Pharmaceuticals SEC Filings SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VINC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
